BHVN - Company ID 0001935979
The table below shows Biohaven Ltd.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|
| Operating cash flow | -$149.92M | -$165.12M | -$102.64M | -$77.64M | -$58.84M |
| Capital expenditure | $0.00 | $461.00K | $440.00K | $735.00K | $246.00K |
| Investing cash flow | $15.21M | $164.88M | $34.03M | -$1.06M | -$246.00K |
| Dividends paid | - | - | - | - | - |
| Stock buybacks | - |
Biohaven Ltd. reported operating cash flow of -$609.44M for fiscal year 2025. That is down 4.6% from -$582.45M in fiscal 2024. Over the 6 fiscal years shown, operating cash flow declined from -$75.96M (FY 2020) to -$609.44M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| - |
| Financing cash flow | $179.02M | $369.00K | $3.42M | $26.67M | $23.03M |